Handoko, M. Louis http://orcid.org/0000-0002-8942-7865
de Man, Frances S.
Brugts, Jasper J.
van der Meer, Peter
Rhodius-Meester, Hanneke F. M.
Schaap, Jeroen
van de Kamp, H. J. Rik
Houterman, Saskia
van Veghel, Dennis
Uijl, Alicia
Asselbergs, Folkert W.
Article History
Accepted: 6 November 2023
First Online: 15 January 2024
Conflict of interest
: M.L. Handoko received an educational grant from Novartis and Boehringer Ingelheim, and speaker/consultancy fees from Novartis, Boehringer Ingelheim, Daiichi Sankyo, Vifor Pharma, AstraZeneca, Bayer, MSD, Abbott and Quin, all not related to this work. F.S. de Man is currently Associate Editor of the <i>Netherlands Heart Journal</i>. J.J. Brugts received speaker/consultancy fees from Bayer, Novartis, Abbott and Vifor Pharma, all not related to this work. He is currently Associate Editor of the <i>Netherlands Heart Journal</i>. P. van der Meer received consultancy fees and/or grants from Novartis, Pharmacosmos, Vifor Pharma, AstraZeneca, Pfizer, Pharma Nord, BridgeBio, Novo Nordisk and Ionis, paid to the institute. H.F.M. Rhodius-Meester performs contract research for Combinostics; all funding is paid to her institution. J. Schaap received an educational grant and speaker/consultancy fees from Boehringer Ingelheim, Daiichi Sankyo, AstraZeneca, General Electric and Novo Nordisk, all not related to this work. H.J. R. van de Kamp, S. Houterman, D. van Veghel, A. Uijl and F.W. Asselbergs declare that they have no competing interests.